An insight into statin use and its association with muscular side effects in clinical practice

Farcaş, Andreea; Bucşa, Camelia; Leucuţa, Daniel; Mogoşan, Cristina; Bojiţă, Marius; Dumitraşcu, Dan L.

doi:10.1515/rjim-2015-0021

Cited by 2 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors, also known as statins, are frequently used for lowering serum low-density lipoprotein cholesterol concentrations and for the prevention of cardiovascular events [ 2 – 6 ]. The safety profile of statins is well established.…”

Section: Introductionmentioning

confidence: 99%

Statin drug-drug interactions in a Romanian community pharmacy

Badiu

Bucşa

Mogoşan

et al. 2016

Medicine and Pharmacy Reports

Self Cite

View full text Add to dashboard Cite

Background and aimStatins are frequently prescribed for patients with dyslipidemia and have a well-established safety profile. However, when associated with interacting dugs, the risk of adverse effects, especially muscular toxicity, is increased.The objective of this study was to identify, characterize and quantify the prevalence of the potential drug-drug interactions (pDDIs) of statins in reimbursed prescriptions from a community pharmacy in Bucharest.MethodsWe analyzed the reimbursed prescriptions including statins collected during one month in a community pharmacy. The online program Medscape Drug Interaction Checker was used for checking the drug interactions and their classification based on severity: Serious – Use alternative, Significant – Monitor closely and Minor.Results132 prescriptions pertaining to 125 patients were included in the analysis. Our study showed that 25% of the patients who were prescribed statins were exposed to pDDIs: 37 Serious and Significant interactions in 31 of the statins prescriptions. The statins involved were atorvastatin, simvastatin and rosuvastatin.ConclusionsStatin pDDIs have a high prevalence and patients should be monitored closely in order to prevent the development of adverse effects that result from statin interactions.

show abstract

Section: Introductionmentioning

confidence: 99%